I3LA reduces the expression of Saa3, related to cholesterol metabolism in CD8+ T cells, through transcriptional inhibition and chromatin accessibility alteration, enhancing the performance of tumour‐infiltrating CD8+ T cells [42]. The gene discussed is CD8A; the disease is neoplasm.